These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27125084)

  • 61. Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment.
    Symeonidis C; Papakonstantinou E; Souliou E; Karakiulakis G; Dimitrakos SA; Diza E
    Acta Ophthalmol; 2011 Jun; 89(4):339-45. PubMed ID: 19764916
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Proliferative vitreoretinopathy].
    Toma C
    Oftalmologia; 2004; 48(3):6-10. PubMed ID: 15598042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Trauma-associated juvenile rhegmatogenous retinal detachment].
    Bopp S
    Klin Monbl Augenheilkd; 2013 Sep; 230(9):879-87. PubMed ID: 23986186
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tailored vitrectomy and laser photocoagulation without scleral buckling for all primary rhegmatogenous retinal detachments.
    Johansson K; Malmsjö M; Ghosh F
    Br J Ophthalmol; 2006 Oct; 90(10):1286-91. PubMed ID: 16837538
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased glutamate levels in the vitreous of patients with retinal detachment.
    Diederen RM; La Heij EC; Deutz NE; Kijlstra A; Kessels AG; van Eijk HM; Liem AT; Dieudonné S; Hendrikse F
    Exp Eye Res; 2006 Jul; 83(1):45-50. PubMed ID: 16530753
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elevated vitreous αB-crystallin in patients with rhegmatogenous retinal detachment and association with proliferative vitreoretinopathy and retinal detachment area.
    Yun J; Min JK
    Int Ophthalmol; 2020 Oct; 40(10):2461-2467. PubMed ID: 32440819
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.
    Loukovaara S; Lehti K; Robciuc A; Pessi T; Holopainen JM; Koli K; Immonen I; Keski-Oja J
    Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):881-8. PubMed ID: 24218041
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Intraocular surgery for secondary retinal detachment in proliferative vitreoretinopathy].
    Pournaras CJ; Donati G
    Klin Monbl Augenheilkd; 1995 May; 206(5):339-42. PubMed ID: 7609381
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Surgical outcomes of vitrectomy for retinal detachment due to macular hole with proliferative vitreoretinopathy].
    Tsuruoka M; Mitamura Y; Nakahara M; Ishida M; Tsukahara I; Kasai H; Yamamoto S; Takeuchi S
    Nippon Ganka Gakkai Zasshi; 1998 Sep; 102(9):583-6. PubMed ID: 9785855
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid.
    Asaria RH; Kon CH; Bunce C; Sethi CS; Limb GA; Khaw PT; Aylward GW; Charteris DG
    Br J Ophthalmol; 2004 Nov; 88(11):1439-42. PubMed ID: 15489490
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment.
    Naveh N; Belkin M; Ben-Chaim O; Weissman C; Treister G
    Ophthalmic Res; 1990; 22(1):3-11. PubMed ID: 2111530
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment.
    Chen SN; Hwang JF; Lin CJ
    Retina; 2012 Feb; 32(2):220-5. PubMed ID: 22277905
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
    Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR
    Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Soluble apoptotic factors and adhesion molecules in rhegmatogenous retinal detachment.
    Ricker LJ; Altara R; Goezinne F; Hendrikse F; Kijlstra A; La Heij EC
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4256-62. PubMed ID: 21372012
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study.
    Kon CH; Asaria RH; Occleston NL; Khaw PT; Aylward GW
    Br J Ophthalmol; 2000 May; 84(5):506-11. PubMed ID: 10781515
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Precollagen III in the vitreous of eyes with proliferative vitreoretinopathy].
    Feng X; Hui Y; Wang L
    Yan Ke Xue Bao; 1998 Jun; 14(2):76-9. PubMed ID: 12580036
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytokine profiling in the sub-silicone oil fluid after vitrectomy surgeries for refractory retinal diseases.
    Kaneko H; Takayama K; Asami T; Ito Y; Tsunekawa T; Iwase T; Funahashi Y; Ueno S; Nonobe N; Yasuda S; Suzumura A; Shimizu H; Kimoto R; Hwang SJ; Terasaki H
    Sci Rep; 2017 May; 7(1):2640. PubMed ID: 28572674
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Personalized Proteomics in Proliferative Vitreoretinopathy Implicate Hematopoietic Cell Recruitment and mTOR as a Therapeutic Target.
    Roybal CN; Velez G; Toral MA; Tsang SH; Bassuk AG; Mahajan VB
    Am J Ophthalmol; 2018 Feb; 186():152-163. PubMed ID: 29246578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular pathogenesis of rhegmatogenous retinal detachment.
    Öhman T; Gawriyski L; Miettinen S; Varjosalo M; Loukovaara S
    Sci Rep; 2021 Jan; 11(1):966. PubMed ID: 33441730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.